Cinacalcet 藥品安全資訊風險溝通表 | 合法藥品大搜索

藥理作用 · Cinacalcet是一種擬鈣製劑，可增加鈣感受性受體對細胞外鈣離子的敏感度。 · 適應症 · 治療透析患者的次發性副甲狀腺機能亢進。 · 用法用量 · Regpara​建議之 ... Read More

Cinacalcet. 藥品學名Cinacalcet. 商. 品. 名英文：Regpara，中文：銳克鈣. 劑型含量25 mg/tab. 廠. 牌Ohara (協和發酵麒麟股份有限公司). 許可證字號衛署藥輸字 ... Read More

2018年8月2日 — 但在台灣健保尚不給付需自費。另一種新藥為擬鈣劑Cinacalcet 25mg (Regpara® 銳克鈣錠)，能作用於鈣敏感受體的新型態藥物 ... Read More

藥理作用機轉. Cinacalcet 是一種擬鈣製劑(calcimimetic)，可增加鈣感受性受體. (​calcium-sensing receptor)對細胞外鈣離子的敏感度。 訊息緣由. 美國FDA 及Health ... Read More

由 劉文治 著作 — Yokoyama K, Ohkido I, Ishida M, et al. Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus: ECO ( ... Read More

Cinacalcet is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is ... Read More

Cinacalcet is in a class of medications called calcimimetics. It works by signaling the body to produce less parathyroid hormone in order to decrease the amount of​ ... Read More

Cinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe. It is used to treat ... Read More

由 Z Junaid 著作 · 2020 — Cinacalcet is a medication used in the management and treatment of secondary hyperparathyroidism (on dialysis population), primary ... Read More

由 JAB Balfour 著作 · 2005 · 被引用 65 次 — Oral cinacalcet hydrochloride (HCl) [Sensipar, Mimpara] is the first in a new class of therapeutic agents, the calcimimetics, and has a novel mechanism of action. Read More